Results from a phase I/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy
暂无分享,去创建一个
G. Gaidano | L. Adès | T. Pabst | C. Récher | N. Vey | M. Bargetzi | C. Papayannidis | K. Nottage | C. Riether | A. Ochsenbein | A. Hultberg | Xuewen Ma | S. Fung | Ulrike Bacher | L. Xiu | P. Shah | D. Gandini | Rouven Müller | Amy Johnson | J. Tryon